Page 70 - 1
P. 70

70
              addicts given methadone maintenance treatment (MT). The street addicts'
              mortality rate was 63 times that expected, compared with official statistics
              for a group of this age and sex distribution. When 53 patients in MT were
              involuntarily expelled from treatment, due to violation of programme rules,
              they returned to the high mortality of street addicts (55 times that expected).
              A group of 34 rehabilitated patients  who left MT with medical consent
              retained the low mortality of MT patients (their mortality rate was 4 times
              that expected). Despite this great improvement in survival, even patients in
              MT showed a moderately elevated mortality (8 times that expected), mainly
              due  to  diseases acquired before entering the treatment programme. It is
              concluded that MT exerts a major improvement in the survival of heroin
              addicts.

      Langendam, M., G. vanBrussel, et al. (2001). "The impact of harm-
      reduction-based methadone treatment on mortality among heroin
      users." Am J Public Health 91(5): 774-80.

      MEDLINE ABSTRACT

              OBJECTIVES: The purpose of this study was to investigate the impact of
              harm-reduction-based methadone programs on mortality among  heroin
              users. METHODS: A prospective  cohort investigation was conducted
              among 827 participants in the Amsterdam Cohort Study. Poisson regression
              was  used  to identify methadone maintenance treatment characteristics
              (dosage, frequency of program attendance, and type of program) that are
              significantly and independently associated with mortality  due  to  natural
              causes and overdose. RESULTS: From 1985 to 1996, 89 participants died
              of natural causes, and 31 died as a result of an overdose. After adjustment
              for  HIV  and  underweight status, there was an increase in natural-cause
              mortality among subjects who left methadone treatment (relative risk [RR]
              = 2.38, 95% confidence interval [CI] = 1.28, 4.55). Leaving treatment was
              also related to higher  overdose  mortality, but only among injection drug
              users  (RR  =  4.55,  95% CI = 1.89, 10.00). CONCLUSIONS: Harm-
              reduction-based methadone treatment, in which the use of  illicit  drugs  is
              tolerated, is strongly related to decreased mortality from natural causes and
              from overdoses. Provision of methadone in  itself,  together  with  social-
              medical care, appears more important than the actual methadone dosage.

      Medical Comorbidity References

      Garfein, R., D. Vlahov, et al. (1996). "Viral infections in short- term
      injection drug users: the prevalence of the hepatitis C, hepatitis B,
   65   66   67   68   69   70   71   72   73   74   75